WHO ICTRP trial
PERFUSIÓN DE LEVOBUPIVACAINA VERSUS FENTANILO A NIVEL DE PLEXO AXILAR EN EL…
EUCTR2009-011123-31-ES · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2009-011123-31-ES |
|---|---|
| Public title | PERFUSIÓN DE LEVOBUPIVACAINA VERSUS FENTANILO A NIVEL DE PLEXO AXILAR EN EL TRATAMIENTO DEL SÍNDROME DOLOROSO REGIONAL COMPLEJO TIPO I |
| Scientific title | PERFUSIÓN DE LEVOBUPIVACAINA VERSUS FENTANILO A NIVEL DE PLEXO AXILAR EN EL TRATAMIENTO DEL SÍNDROME DOLOROSO REGIONAL COMPLEJO TIPO I |
| Primary sponsor | FUNDACION PARA LA INVESTIGACION BIOMEDICA HOSPITAL UNIVERSITARIO 12 DE OCTUBRE |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Spain |
| Conditions | SÍNDROME DOLOROSO REGIONAL COMPLEJO TIPO I |
| Interventions | Trade Name: CHIROCANE 1,25 mg/ml solución inyectable Pharmaceutical Form: Solution for infusion INN or Proposed INN: LEVOBUPIVACAINA HIDROCLORURO Other descriptive name: LEVOBUPIVACAINE HYDROCHLORIDE Concentration unit: % percent… |
| Registration date | Feb 24, 2010 |
| Target size | 64 |
| Secondary IDs | EC08/00187 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: